Bundled Intervention for Opioid Overdose

(B-CARE Trial)

This trial tests a new approach to prevent repeat opioid overdoses after patients leave the emergency department (ED). The bundled intervention includes telehealth (remote medical appointments), peer support, buprenorphine medication, and connections to ongoing care. The goal is to increase treatment participation and reduce opioid overdose deaths. Individuals who have experienced an opioid overdose in the past year, received buprenorphine in the ED, and are willing to continue its use may be suitable for this trial. As a Phase 4 trial, this research aims to understand how the already FDA-approved treatment benefits more patients, offering a chance to contribute to broader knowledge and potentially improve outcomes for others.

The trial does not specify if you need to stop taking your current medications, but you must be willing to continue taking buprenorphine after leaving the emergency department. If you are taking other prescribed opioids for more than three months, you cannot participate.

Research has shown that the combined approach for preventing opioid overdose, which includes online healthcare, peer support, and buprenorphine treatment, is generally manageable for individuals. Previous studies have found that online healthcare services for opioid use disorder are safe and effective, helping patients adhere better to their treatment plans.

Studies have also demonstrated that using online healthcare to provide buprenorphine, a medication that reduces cravings and withdrawal symptoms from opioids, is effective and safe. No major negative effects were reported, indicating the treatment's safety.

Researchers are excited about the Bundled Intervention for opioid overdose because it offers a comprehensive approach that combines several support mechanisms. Unlike the standard care, which mainly involves initial buprenorphine treatment and self-navigation through treatment options, the Bundled Intervention integrates scheduled peer support and telehealth consultations with addiction physicians. This method ensures continuous guidance and support up to three months after hospital discharge, aiming to enhance recovery rates and provide a more structured path to long-term addiction treatment. By leveraging technology and peer support, this intervention could significantly improve engagement and outcomes for individuals recovering from opioid overdose.

This trial will compare a bundled intervention with usual care for opioid overdose. Research has shown that combining treatments, such as online healthcare services, peer support, and the medication buprenorphine, can aid individuals with opioid addiction. Participants in the experimental group will receive this bundled intervention, which includes scheduled peer support contacts, buprenorphine treatment with addiction physicians via telehealth, and linkage to definitive addiction treatment programs. Studies have found that online healthcare helps individuals adhere to their medication and remain in treatment longer. Peer support effectively increases engagement in recovery and access to services. Buprenorphine is associated with fewer opioid overdoses and serious health issues related to opioids. Together, these treatments aim to encourage more people to begin treatment and prevent repeat overdoses after leaving the emergency room.²³⁴⁶⁷